MD
Maryland Senate Bill SB394

Maryland 2022 Regular Session

Maryland Senate Bill SB394

Introduced
1/24/22  
Refer
1/24/22  
Report Pass
3/11/22  
Engrossed
3/17/22  
Refer
3/18/22  
Report Pass
4/7/22  
Enrolled
4/11/22  
Chaptered
5/12/22  

Caption

Statewide Targeted Overdose Prevention (STOP) Act of 2022

Latest MD SB394 Activity

View All Events: MD 2022 Regular Session SB394

Companion Bills

MD HB408

Crossfiled Statewide Targeted Overdose Prevention (STOP) Act of 2022

Previously Filed As

MD HB408

Statewide Targeted Overdose Prevention (STOP) Act of 2022

MD HB3375

STOP Fentanyl Overdoses Act of 2023 Support, Treatment, and Overdoses Prevention of Fentanyl Overdoses Act of 2023

MD SB57

Controlled substances: overdose prevention program.

MD SB1785

Stop Fentanyl Overdoses Act of 2023

MD HB1094

Public Health - Overdose Prevention Site Pilot Program

MD HB729

Public Health - Use of Opioid Restitution Fund and Training Under the Overdose Response Program

MD SB594

Public Health - Use of Opioid Restitution Fund and Training Under the Overdose Response Program

MD SB00483

An Act Concerning The Prevention And Treatment Of Opioid Dependency And Opioid Overdoses In The State.

MD AB362

Controlled substances: overdose prevention program.

MD HB852

Educational Institutions - Opioid Overdose-Reversing Medications - Policy Requirements (Protecting Our Kids From Overdoses Act)

Similar Bills

MD HB408

Statewide Targeted Overdose Prevention (STOP) Act of 2022

MD SB793

Public Health - Opioid Overdose Reversal Drugs

MD HB572

Public Health - Opioid Overdose Reversal Drugs

MD SB459

Education and Health - Emergency Use Epinephrine - Alterations

MD HB420

Education and Health - Emergency Use Epinephrine - Alterations

MD HB536

Education and Health - Emergency Use Epinephrine - Alterations

MD HB86

Public and Nonpublic Schools - Bronchodilators - Use, Availability, Training, and Policies

MD SB180

Public and Nonpublic Schools - Bronchodilators - Use, Availability, Training, and Policies